HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zheng, Y. Articles by Monestier, M. Search for Related Content PubMed PubMed Citation Articles by Zheng, Y. Articles by Monestier, M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Autoimmune Diseases Hazardous Substances DB MERCURIC CHLORIDE MERCURY COMPOUNDS

Inhibitory Signal Override Increases Susceptibility to Mercury-Induced Autoimmunity ¹

Department of Microbiology and Immunology, Temple University School of Medicine, Philadelphia, PA 19140

After exposure to subtoxic doses of heavy metals such as mercury, H-2^s mice develop an autoimmune syndrome consisting of the rapid production of IgG autoantibodies that are highly specific for nucleolar autoantigens and a polyclonal increase in serum IgG1 and IgE. In this study, we explore the role of two inhibitory immunoreceptors, CTLA-4 and FcRIIB, in the regulation of mercury-induced autoimmunity. In susceptible mice treated with mercuric chloride (HgCl₂), administration of a blocking anti-CTLA-4 Ab resulted in a further increase in anti-nucleolar autoantibodies and in total serum IgG1 levels. Furthermore, in some DBA/2 mice, which are normally resistant to heavy metal-induced autoimmunity, anti-CTLA-4 treatment leads to the production of anti-nucleolar Abs, thereby overcoming the genetic restriction of the disease. In mice deficient for the FcRIIB, HgCl₂ administration did not trigger autoantibody production, but resulted in an increase in IgE serum levels. Taken together, these results indicate that different inhibitory mechanisms regulate various manifestations of this autoimmune syndrome.

This article has been cited by other articles:

				S. E. Ziemba, S. L. Menard, M. J. McCabe Jr, and A. J. Rosenspire T-cell receptor signaling is mediated by transient Lck activity, which is inhibited by inorganic mercury FASEB J, June 1, 2009; 23(6): 1663 - 1671. [Abstract] [Full Text] [PDF]

				D. S. Vinay, J. D. Kim, and B. S. Kwon Amelioration of Mercury-Induced Autoimmunity by 4-1BB J. Immunol., October 15, 2006; 177(8): 5708 - 5717. [Abstract] [Full Text] [PDF]

				S. E. Ziemba, R. R. Mattingly, M. J. McCabe Jr., and A. J. Rosenspire Inorganic Mercury Inhibits the Activation of LAT in T-Cell Receptor-Mediated Signal Transduction Toxicol. Sci., January 1, 2006; 89(1): 145 - 153. [Abstract] [Full Text] [PDF]

				Y. Zheng, S. Gallucci, J. P. Gaughan, J. A. Gross, and M. Monestier A Role for B Cell-Activating Factor of the TNF Family in Chemically Induced Autoimmunity J. Immunol., November 1, 2005; 175(9): 6163 - 6168. [Abstract] [Full Text] [PDF]

				K. M. Pollard, M. Arnush, P. Hultman, and D. H. Kono Costimulation Requirements of Induced Murine Systemic Autoimmune Disease J. Immunol., November 1, 2004; 173(9): 5880 - 5887. [Abstract] [Full Text] [PDF]

				T. Keler, E. Halk, L. Vitale, T. O'Neill, D. Blanset, S. Lee, M. Srinivasan, R. F. Graziano, T. Davis, N. Lonberg, et al. Activity and Safety of CTLA-4 Blockade Combined with Vaccines in Cynomolgus Macaques J. Immunol., December 1, 2003; 171(11): 6251 - 6259. [Abstract] [Full Text] [PDF]